GL
Damora Therapeutics, Inc.
GLTO · NASDAQ
$22.31 +0.22% (+$0.05)
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
25 /100
Unstable Beta 1.60x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre GLTO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jennifer A. Jarrett
Employees
7
Headquarters
Boston